A robust multiplex immunoaffinity mass spectrometry assay (PromarkerD) for clinical prediction of diabetic kidney disease

BACKGROUND: PromarkerD is a novel proteomics derived blood test for predicting diabetic kidney disease (DKD). The test is based on an algorithm that combines the measurement of three plasma protein biomarkers (CD5L, APOA4, and IBP3) with three clinical variables (age, HDL-cholesterol, and eGFR). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Bringans, Scott, Ito, Jason, Casey, Tammy, Thomas, Sarah, Peters, Kirsten, Crossett, Ben, Coleman, Orla, Ebhardt, Holger A., Pennington, Stephen R., Lipscombe, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576806/
https://www.ncbi.nlm.nih.gov/pubmed/33093819
http://dx.doi.org/10.1186/s12014-020-09302-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576806/
https://www.ncbi.nlm.nih.gov/pubmed/33093819
http://dx.doi.org/10.1186/s12014-020-09302-w

Ejemplares similares